EFPIA - NEWSLETTER

EFPIA Newsletter 05 July 2018

EFPIA President: Next EU Commission should prioritise competitiveness in pharma innovation

The next European Commission should focus on the bloc’s role in the global context of innovation, as China is “decisive” about creating a reliable framework for intellectual property and connecting biotech start-ups and digital companies, EFPIA’s President Stefan Oschmann told EURACTIV.com in an interview.

Videos

A lifetime of breakthroughs

We were born to end patients’ suffering. To extend life and improve its quality. And right now, after decades of tireless medical innovation, we still won’t rest.

pharma.be meets Nathalie Moll

EFPIA Director General talked with pharma.be about the Innovative Medicines Initiative, the main challenges facing the pharmaceutical industry, and patient engagement

Events

27 SEP 2018

28052018 ITCC-P4 International Workshop: Improving pediatric oncology drug development... Amsterdam, The Netherlands

The overarching goal is to streamline and improve the development of new oncology drugs for children and adolescents...

Learn more →

20 NOV 2018

War On Cancer Europe 2018 London

The technological revolution and the future of patient engagement - A conference organised by The Economist

Learn more →

We published

2018: The pharmaceutical industry in figures 28 June 2018 (Publications)

The Pharmaceutical Industry: a key asset to scientific and medical progress

What we are reading

Drugs companies are rising to the challenges of research into superbugs 04 July 2018 (Financial Times)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶